Biotia

Private

Long Island City, New YorkHealthcare & Life Scienceshttps://biotia.io

Last Round

Series A

Aug 23, 2022

Total Funding Raised

$10.4M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Biotia is a health technology company that provides a sequencing-based technology and proprietary AI-powered software to identify microorganisms and antimicrobial resistance.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical AI, Precision Medicine, Telemedicine

Business Model

B2B

Customer Profile

Usage-Based SaaS, Subscription SaaS, Government Contracts

AI Layer

Application

Keywords

next-generation sequencingNGSinfectious disease diagnosticsantimicrobial resistanceAMRpathogen identificationAI diagnosticsmetagenomicsclinical metagenomicspathogen surveillancegenomic epidemiologybioinformatics softwarelaboratory-developed testLDTCLIA labinfection controlpublic health technology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Biotia Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Biotia Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Aug 23, 2022
Seed	Dec 10, 2019

View all Funding Rounds

Key People

Founding team and executive leadership

Niamh B. O'Hara

CEO And Co-founder

Founding Team

David Danko

Chief Technology Officer

Executive Team

Biotia Investors

Notable investors and investment history

Investor	Rounds
Phoenix Venture Partners	Series A
SeedtoB Capital	Series A
Tau Ventures	Series A
SK Square Americas	Series A
DigitalDx Ventures	Series A
Continuum Health Ventures	Series A
SpringTide Ventures	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 15, 2026
Monthly visitors increased 41% MoM, reaching 3.3K.
Sep 8, 2025
Launched a new 'test to treat' option for recurrent UTIs.

View all signals

Biotia Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Biotia Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Biotia's valuation, stock price, and market status.

Firmographic Details

HeadquartersLong Island City, New York

Employee Range26

Year Founded2016

Last FundingAug 23, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.